These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 25619468)

  • 41. Neutralizing and cross-neutralizing antibody titres induced by bivalent and quadrivalent human papillomavirus vaccines in the target population of organized vaccination programmes.
    Barzon L; Squarzon L; Masiero S; Pacenti M; Marcati G; Mantelli B; Gabrielli L; Pascucci MG; Lazzarotto T; Caputo A; Palù G
    Vaccine; 2014 Sep; 32(41):5357-62. PubMed ID: 25045814
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Safety and immunogenicity of a vaccine targeting human papillomavirus types 6, 11, 16 and 18: a randomized, double-blind, placebo-controlled trial in Chinese males and females.
    Li R; Li Y; Radley D; Liu Y; Huang T; Sings HL; Zhang L; Wang W; Zhong X; Saah AJ
    Vaccine; 2012 Jun; 30(28):4284-91. PubMed ID: 22433961
    [TBL] [Abstract][Full Text] [Related]  

  • 43. An open-label, randomized, multicenter study of the safety, tolerability, and immunogenicity of quadrivalent human papillomavirus (types 6/11/16/18) vaccine given concomitantly with diphtheria, tetanus, pertussis, and poliomyelitis vaccine in healthy adolescents 11 to 17 years of age.
    Vesikari T; Van Damme P; Lindblad N; Pfletschinger U; Radley D; Ryan D; Vuocolo S; Haupt RM; Guris D
    Pediatr Infect Dis J; 2010 Apr; 29(4):314-8. PubMed ID: 19952980
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Gardasil 9 joins the fight against cervix cancer.
    Cuzick J
    Expert Rev Vaccines; 2015; 14(8):1047-9. PubMed ID: 26028344
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Human papillomavirus vaccination in Africa: An airway perspective.
    McGuire JK; Kabagenyi F; Peer S
    Int J Pediatr Otorhinolaryngol; 2023 Feb; 165():111423. PubMed ID: 36681046
    [TBL] [Abstract][Full Text] [Related]  

  • 46. High-dose sublesional bevacizumab (avastin) for pediatric recurrent respiratory papillomatosis.
    Sidell DR; Nassar M; Cotton RT; Zeitels SM; de Alarcon A
    Ann Otol Rhinol Laryngol; 2014 Mar; 123(3):214-21. PubMed ID: 24633948
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Recurrent respiratory papillomatosis: a longitudinal study comparing severity associated with human papilloma viral types 6 and 11 and other risk factors in a large pediatric population.
    Wiatrak BJ; Wiatrak DW; Broker TR; Lewis L
    Laryngoscope; 2004 Nov; 114(11 Pt 2 Suppl 104):1-23. PubMed ID: 15514560
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The efficacy and safety of the quadrivalent human papillomavirus 6/11/16/18 vaccine gardasil.
    Haupt RM; Sings HL
    J Adolesc Health; 2011 Nov; 49(5):467-75. PubMed ID: 22018560
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Human papilloma virus (HPV)-associated gynecological alteration in mothers of children with recurrent respiratory papillomatosis during long-term observation.
    Gerein V; Schmandt S; Babkina N; Barysik N; Coerdt W; Pfister H
    Cancer Detect Prev; 2007; 31(4):276-81. PubMed ID: 17935912
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Efficacy of microsurgery in combined with topical-PDT in treating recurrent respiratory papillomatosis: compare JORRP with AORRP.
    Yang S; Zhou C; Sun B; Wang F; Han Z; Zhang H; Han J; Shen Y; Zhang J
    Acta Otolaryngol; 2019 Dec; 139(12):1133-1139. PubMed ID: 31556770
    [No Abstract]   [Full Text] [Related]  

  • 51. Prevalence of diabetes mellitus and its impact on disease severity in adult recurrent respiratory papillomatosis.
    Lee CJ; Allen CT; Merati AL
    Otolaryngol Head Neck Surg; 2013 Oct; 149(4):603-7. PubMed ID: 23851281
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Gardasil-9 Vaccine as a Possible Treatment Option for Human Papillomavirus Conjunctival Papilloma.
    Seth I; Roberts P; Cadieux D
    Ophthalmology; 2023 May; 130(5):532. PubMed ID: 36127187
    [No Abstract]   [Full Text] [Related]  

  • 53. Prolonged remission of juvenile-onset respiratory papillomatosis: a post-expositional role of the tetravalent anti-HPV vaccine?
    Yi L; Vaudaux B; Sandu K; Nisa L
    Int J Pediatr Otorhinolaryngol; 2014 Feb; 78(2):388-90. PubMed ID: 24388316
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Risk factors for aggressive recurrent respiratory papillomatosis in adults and juveniles.
    Omland T; Akre H; Lie KA; Jebsen P; Sandvik L; Brøndbo K
    PLoS One; 2014; 9(11):e113584. PubMed ID: 25419846
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Systematic review of the use of human papillomavirus vaccine as adjuvant therapy for juvenile-onset recurrent respiratory papillomatosis.
    Park I; Carbone S; Preciado D
    Int J Pediatr Otorhinolaryngol; 2022 Nov; 162():111314. PubMed ID: 36116179
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Long-Term Follow-Up on Systemic Bevacizumab Treatment in Recurrent Respiratory Papillomatosis.
    Evers G; Schliemann C; Beule A; Schmidt LH; Schulze AB; Kessler C; Hoffmann TK; Wiewrodt R; Groll AH; Bleckmann A; Rudack C; Berdel WE; Mohr M
    Laryngoscope; 2021 Jun; 131(6):E1926-E1933. PubMed ID: 33382105
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Estimating the prevalence of and treatment patterns for juvenile onset recurrent respiratory papillomatosis in Australia pre-vaccination: a pilot study.
    Novakovic D; Cheng AT; Cope DH; Brotherton JM
    Sex Health; 2010 Sep; 7(3):253-61. PubMed ID: 20719212
    [TBL] [Abstract][Full Text] [Related]  

  • 58. HspE7 treatment of pediatric recurrent respiratory papillomatosis: final results of an open-label trial.
    Derkay CS; Smith RJ; McClay J; van Burik JA; Wiatrak BJ; Arnold J; Berger B; Neefe JR
    Ann Otol Rhinol Laryngol; 2005 Sep; 114(9):730-7. PubMed ID: 16240938
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Economic impact of recurrent respiratory papillomas in a UK adult population.
    Harrison A; Montgomery J; Macgregor FB
    J Laryngol Otol; 2016 Jul; 130(7):645-9. PubMed ID: 27188701
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinical characteristics and HPV type in recurrent respiratory papillomatosis in Colombia.
    Cuello G; Sánchez GI; Jaramillo R; Quintero K; Baena A; O'Byrne A; Reyes AJ; Santamaría C; Reina JC; Muñoz N
    Salud Publica Mex; 2013 Aug; 55(4):416-20. PubMed ID: 24165718
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.